Get App Open
In App
Lending
Lending
Open App

Ankur Drugs & Pharma Ltd.

BSE: 531683 | NSE: ANKURDRUGS | Series: NA | ISIN: INE238D01012 | SECTOR: Pharmaceuticals

BSE Live

Sep 05, 15:38
3.93 0.00 (0.00%)
Volume
No Data Available
9,225
  • Prev. Close

    3.93

  • Open Price

    3.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ankur Drugs & Pharma is not listed on BSE

NSE Live

Sep 10, 15:31
3.65 0.00 (0.00%)
Volume
No Data Available
10,260
  • Prev. Close

    3.65

  • Open Price

    3.75

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ankur Drugs & Pharma is not listed on NSE
Company History - Ankur Drugs & Pharma
YEAR                       EVENTS
 1995 - Mridol Pharmaceuticals Limited was incorporated on 9th
 February,
        with the Registrar of Companies, Maharashtra at Mumbai and
        certificate of commencement of business was obtained on 7th
        March.  The Company was promoted by Shri Sandeep Parwal and
 Shri
        Harinarayan Attal.
 
      - The Company proposes to set up a project for manufacturing,
        filling and packing of hard gelatine capsules at the Union
        Territory of Daman & Diu.
 
 1996 - The Company's Public Issue of 57,00,000 Equity shares of
 Rs.10/-
        each for cash at par opened for subscription on 15th
 February,
        and was over subscribed.
 
 1997 - The Industrial Development Bank of India has sanctioned a
 Term
        Loan of Rs.490/- Lakhs during the year against the expansion
 of
        the project for the pharmaceutical formulation in addition to
        manufacturing of Empty Hard Gelatine Capsules Filling and
 Blister
        Packing of Capsules.
 
 1998 - The name of the company be and is hereby changed from MRIDOL
        PHARMACEUTICALS LIMITED to ANKUR DRUGS AND PHARMA LIMITED.
 
 1999 - The company is at present manufacturing formulations on loan
        licence basis for reputed companies like Cipla Ltd., Nicholas
        Piramal (India) Ltd.
 
      - The company is consuming energy by way of Electricity and
        LDO/Furnace oil which taken together are important inputs and
        receives the focussed attention of the Board.
 
 
 2003
 
 - Appointed Mr Purnandu Jain as Chairman and Managing Director of the
 company.
 
 
 2007
 
 - The Company has signed a Term Sheet jointly with Labtech of GMBH-
 Germany & APR (Applied Pharma Research) for a exclusive Intellectual
 property rights for a novel technology.
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347